Pharmacogenomic analysis of the triplet combination of gemcitabine, oxaliplatin and cetuximab as salvage therapy for metastatic colorectal cancer (mCRC) patients

  1. Bandres, E.
  2. Rodriguez, J.
  3. Hernandez, A.
  4. Bitarte, N.
  5. Ramirez, N.
  6. Diaz-Gonzalez, J. A.
  7. Chopitea, A.
  8. Ponz, M.
  9. Zarate, R. N.
  10. Garcia-Foncillas, J.
Revue:
EJC SUPPLEMENTS

ISSN: 1359-6349

Année de publication: 2009

Volumen: 7

Número: 2

Pages: 113-113

Congreso: 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology

Type: Communication dans un congrès

DOI: 10.1016/S1359-6349(09)70388-X GOOGLE SCHOLAR
La source de données: WoS